Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
ALNY
Alnylam Pharmaceuticals Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Alnylam Pharmaceuticals Inc (ALNY) Earnings
Last reported
April 30, 2026
EPS estimate
$0.97
EPS actual
—
Revenue est.
$1.1B
Revenue actual
—
Related:
ALNY overview
·
ALNY financials
·
ALNY news